EFTA01201095.pdf

AOBiome, LLC Financial Overview Background Formed: December 2012 Purchased Nitroceutic, LLC: January 2013 Began business operations: January 2013 Closed Series A-1 Preferred: January 2014, $931,338 Issuance of Series A-2 Preferred: March 2014, $470,877 Series B Terms Investment Amount to be raised: $4.0 million Security: Series B Preferred Stock Shares offered: 2,666,667 Price per share: $1.50 Pre-money valuation: $20 million Closing date: August 2014 Preferences Series B Preferred Stock Preference over all other classes Series A and Founders $2,177,000 Common and Incentive Shares $0 Board Seats Series A 1 L. Barshack Founders 2 J. Heywood and W. Thompson Net Worth The Company's balance sheet at May 31, 2014 reflects the following approximate amounts: Total Asset at Fair Value: $ 223,739 ($204,000 cash) Total Liabilities: $ 105,826 Preferred Stock: $ 1,403,472 Net Worth: $ 117,913 The Company has an accumulated deficit of $1,252,538 as of May 31, 2014 and the year-to-date net loss as of May 31, 2014 of $486,405. EFTA01201095